Precision Bio

Precision Biosensor, Inc. (Precision Bio) is a South Korean in-vitro diagnostics (IVD) company founded in 2015 and headquartered in Daejeon, South Korea. The company specialises in Point-of-Care Testing (POCT) by developing and commercialising biomarker diagnostic products based on its proprietary Time-Resolved Fluorescence (TRF) immunodiagnosis and multiplex clinical chemistry platforms. Precision Bio's TRF technology enables highly sensitive detection of single-digit picogram levels of biomarkers, offering accuracy comparable to lab-based assays at a portable scale. The company holds over 370 diagnostic-related patents worldwide and has received FDA, CE, MFDS, and PMDA certifications. Listed on South Korea's KOSDAQ market since 2020.